Top Markets
Coin of the day
LungLife AI, Inc. LungLife AI, Inc.

LungLife AI, Inc.

LLAI
株式のランク #41525
LungLife AI, Inc. is a clinical diagnostics enterprise focused on creating... LungLife AI, Inc. is a clinical diagnostics enterprise focused on creating AI-powered solutions for detecting lung cancer. The company is actively developing LungLB, an advanced blood-based test that harnesses artificial intelligence and machine learning. LungLB is designed to precisely identify and quantify circulating tumor cells (CTCs), ultimately aiming to minimize manual intervention and elevate diagnostic performance. The organization, which was previously known as Cynvenio Biosystems, Inc., adopted the LungLife AI, Inc. moniker in May of 2019. Its operations are based in Thousand Oaks, California.
株価
$0.05646911
最終同期: 2025-05-28
時価総額
$17.31K
変化(1日)
-1.67%
変化(1年)
0.00%
US
取引 LungLife AI, Inc. (LLAI)

カテゴリー

LungLife AI, Inc.(LLAI)のP/B比率
2026 時点のP/B比率 TTM: 0
LungLife AI, Inc. の最新の財務報告および株価によると、現在のP/B比率(TTM)は 0 です。2026 年末時点でのP/B比率は 0 でした。
LungLife AI, Inc. の P/B 比率の履歴(2026 ~ 2026)
各年末時点のP/B比率
P/B比率 変化
提供された日付のデータは十分ではありません。
同業他社のP/B比率
企業 P/B比率 P/B比率の差
4.0441 -
US
2.6166 -
US
- -
CN
28.7765 -
US
21.3575 -
US